HUP0004735A2 - Dofetilid polimorf alakjai, eljárás előállításukra, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Dofetilid polimorf alakjai, eljárás előállításukra, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0004735A2 HUP0004735A2 HU0004735A HUP0004735A HUP0004735A2 HU P0004735 A2 HUP0004735 A2 HU P0004735A2 HU 0004735 A HU0004735 A HU 0004735A HU P0004735 A HUP0004735 A HU P0004735A HU P0004735 A2 HUP0004735 A2 HU P0004735A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- polymorphs
- dofetilide polymorphs
- Prior art date
Links
- IXTMWRCNAAVVAI-UHFFFAOYSA-N dofetilide Chemical compound C=1C=C(NS(C)(=O)=O)C=CC=1CCN(C)CCOC1=CC=C(NS(C)(=O)=O)C=C1 IXTMWRCNAAVVAI-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002994 dofetilide Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 abstract 2
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A találmány szerinti (A) képlettel jellemezhető P162, P162a és P143dofetilid polimorfok differenciálkalorimetriás vizsgálatban rendre 162°C, 160 °C és 144 °C névleges hőmérsékleten endoterm csúcsot mutatnak.A találmány tárgykörébe tartoznak a fenti dofetilid polimorfokelőállítási eljárásai, az azokat tartalmazó gyógyászati készítmény,továbbá a fenti polimorfok alkalmazása antiarritmiás szerek, valamintszívbénulás, különösen vértolulásos szívszélhűdés kezelésére szolgálógyógyászati készítmények előállítására. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9722662.5A GB9722662D0 (en) | 1997-10-27 | 1997-10-27 | Polymorphs |
| PCT/EP1998/006641 WO1999021829A1 (en) | 1997-10-27 | 1998-10-09 | Dofetilide polymorphs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004735A2 true HUP0004735A2 (hu) | 2001-10-28 |
| HUP0004735A3 HUP0004735A3 (en) | 2001-12-28 |
Family
ID=10821150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004735A HUP0004735A3 (en) | 1997-10-27 | 1998-10-09 | Dofetilide polymorphs, process for their preparation, their use and pharmaceutical compositions containing them |
Country Status (47)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10019067C1 (de) * | 2000-04-18 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung |
| US7326772B2 (en) * | 2005-05-12 | 2008-02-05 | Penta Biotech, Inc. | Peptide for assaying hERG channel binding |
| CZ307826B6 (cs) | 2017-12-01 | 2019-05-29 | Farmak, A.S. | Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu) |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG18188A (en) * | 1986-05-01 | 1992-09-30 | Pfizer Ltd | Process for preparation anti-arhythmia agents |
| EP0898964A1 (en) * | 1997-08-19 | 1999-03-03 | Pfizer Inc. | Method for treating heart failure |
-
1997
- 1997-10-27 GB GBGB9722662.5A patent/GB9722662D0/en not_active Ceased
-
1998
- 1998-09-10 UA UA2000042087A patent/UA67755C2/uk unknown
- 1998-10-08 TW TW087116747A patent/TW449589B/zh not_active IP Right Cessation
- 1998-10-09 DK DK98965638T patent/DK1027329T3/da active
- 1998-10-09 CA CA002307121A patent/CA2307121C/en not_active Expired - Fee Related
- 1998-10-09 DE DE69811256T patent/DE69811256T2/de not_active Expired - Fee Related
- 1998-10-09 SI SI9830347T patent/SI1027329T1/xx unknown
- 1998-10-09 TR TR2000/01135T patent/TR200001135T2/xx unknown
- 1998-10-09 KR KR10-2000-7004471A patent/KR100366167B1/ko not_active IP Right Cessation
- 1998-10-09 JP JP2000517941A patent/JP3569495B2/ja not_active Expired - Fee Related
- 1998-10-09 AU AU21512/99A patent/AU737668B2/en not_active Ceased
- 1998-10-09 NZ NZ503785A patent/NZ503785A/en unknown
- 1998-10-09 ID IDW20000767A patent/ID24658A/id unknown
- 1998-10-09 PT PT98965638T patent/PT1027329E/pt unknown
- 1998-10-09 AT AT98965638T patent/ATE232199T1/de not_active IP Right Cessation
- 1998-10-09 SK SK586-2000A patent/SK5862000A3/sk unknown
- 1998-10-09 HU HU0004735A patent/HUP0004735A3/hu unknown
- 1998-10-09 EP EP98965638A patent/EP1027329B1/en not_active Expired - Lifetime
- 1998-10-09 US US09/423,986 patent/US6124363A/en not_active Expired - Lifetime
- 1998-10-09 WO PCT/EP1998/006641 patent/WO1999021829A1/en not_active Application Discontinuation
- 1998-10-09 CN CNB988106213A patent/CN1146537C/zh not_active Expired - Fee Related
- 1998-10-09 BR BR9813308-0A patent/BR9813308A/pt not_active Application Discontinuation
- 1998-10-09 IL IL13543598A patent/IL135435A0/xx not_active IP Right Cessation
- 1998-10-09 ES ES98965638T patent/ES2190620T3/es not_active Expired - Lifetime
- 1998-10-09 PL PL340805A patent/PL197379B1/pl unknown
- 1998-10-09 YU YU24000A patent/YU24000A/sh unknown
- 1998-10-09 EA EA200000365A patent/EA002656B1/ru not_active IP Right Cessation
- 1998-10-22 AP APAP/P/1998/001371A patent/AP906A/en active
- 1998-10-22 PA PA19988462001A patent/PA8462001A1/es unknown
- 1998-10-23 PE PE1998001003A patent/PE122199A1/es not_active Application Discontinuation
- 1998-10-23 AR ARP980105310A patent/AR015193A1/es unknown
- 1998-10-23 MY MYPI98004829A patent/MY123352A/en unknown
- 1998-10-26 HN HN1998000165A patent/HN1998000165A/es unknown
- 1998-10-26 DZ DZ980242A patent/DZ2632A1/xx active
- 1998-10-26 TN TNTNSN98193A patent/TNSN98193A1/fr unknown
- 1998-10-26 MA MA25313A patent/MA24683A1/fr unknown
- 1998-10-26 UY UY25222A patent/UY25222A1/es not_active IP Right Cessation
- 1998-10-26 ZA ZA9809719A patent/ZA989719B/xx unknown
- 1998-10-27 GT GT199800165A patent/GT199800165A/es unknown
- 1998-10-27 CO CO98062885A patent/CO4970768A1/es unknown
- 1998-11-28 SA SA98190834A patent/SA98190834B1/ar unknown
-
1999
- 1999-01-08 UY UY25341A patent/UY25341A1/es not_active IP Right Cessation
-
2000
- 2000-03-31 IS IS5426A patent/IS2179B/is unknown
- 2000-04-20 OA OA1200000117A patent/OA11350A/en unknown
- 2000-04-24 BG BG104373A patent/BG64125B1/bg unknown
- 2000-04-27 NO NO20002191A patent/NO325630B1/no not_active IP Right Cessation
- 2000-04-27 HR HR970680A patent/HRP20000247B1/xx not_active IP Right Cessation
-
2001
- 2001-06-21 HK HK01104340A patent/HK1033933A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69715888D1 (de) | Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel | |
| TR199900848T2 (xx) | Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�. | |
| DK623784D0 (da) | 11beta-aryloestradiener, fremgangsmaader til fremstilling heraf og farmaceutiske praeparater med indhold heraf | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| MY133647A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
| HUP0100949A2 (hu) | Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények | |
| HUP0203378A2 (hu) | Gyógyszerészeti vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0102472A2 (hu) | Nitrogén-oxid szintáz inhibitorként alkalmazható amidinoszármazékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| ATE188469T1 (de) | Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| ZA851552B (en) | Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds | |
| ATE2265T1 (de) | Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. | |
| ES8800161A1 (es) | Procedimiento para la fabricacion de derivados quinolilglicinamidas | |
| ES8607271A1 (es) | Amidinohidrazonas | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| ES8305684A1 (es) | Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas. | |
| HUP0004735A2 (hu) | Dofetilid polimorf alakjai, eljárás előállításukra, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| TR199802042T2 (xx) | Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�. | |
| NO883074D0 (no) | Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater. | |
| TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
| AU1264488A (en) | Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds | |
| ATE61589T1 (de) | Isohexid-nukleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ES8506717A1 (es) | Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina | |
| YU6087A (en) | Process for obtaining 2-benzimidazole-ilalkylthiosulphinyl or sulphonyl derivatives | |
| ES8802311A1 (es) | Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: PFIZER IRELAND PHARMACEUTICALS, A PARTNERSHIP , IE Free format text: FORMER OWNER(S): PFIZER RESEARCH AND DEVELOPMENT COMPANY N.V./S.A., IE |